Literature DB >> 26974275

Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary.

J M Watts1, X V Wang2,3, R T Swords1, E Paietta4, D Douer5, S M Lugar6, H F Fernandez7, J M Rowe8, H M Lazarus9, M S Tallman5, M R Litzow10.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26974275      PMCID： PMC5699708          DOI： 10.1038/bmt.2016.44

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation.

Authors:  D R Simpson; T J Nevill; J D Shepherd; H C Fung; D E Horsman; S H Nantel; L M Vickars; H J Sutherland; C L Toze; D E Hogge; H G Klingemann; S C Naiman; M J Barnett
Journal:  Bone Marrow Transplant       Date:  1998-08       Impact factor: 5.483

2.  Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patients.

Authors:  Justin M Watts; Xin Victoria Wang; Mark R Litzow; Selina M Luger; Hillard M Lazarus; Peter A Cassileth; Hugo F Fernandez; Dan Douer; Lynette Zickl; Elisabeth Paietta; Jacob M Rowe; Martin S Tallman
Journal:  Leuk Res       Date:  2014-06-02       Impact factor: 3.156

3.  Extramedullary sites of leukemia relapse after transplant.

Authors:  Isabel Cunningham
Journal:  Leuk Lymphoma       Date:  2006-09

4.  Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.

Authors:  Jeffery M Klco; David H Spencer; Christopher A Miller; Malachi Griffith; Tamara L Lamprecht; Michelle O'Laughlin; Catrina Fronick; Vincent Magrini; Ryan T Demeter; Robert S Fulton; William C Eades; Daniel C Link; Timothy A Graubert; Matthew J Walter; Elaine R Mardis; John F Dipersio; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-06       Impact factor: 31.743

5.  Late relapses in acute myeloid leukemia: analysis of characteristics and outcome.

Authors:  Dushyant Verma; Hagop Kantarjian; Stefan Faderl; Susan O'Brien; Sherry Pierce; Khanh Vu; Emil Freireich; Michael Keating; Jorge Cortes; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2010-05

6.  Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.

Authors:  Thomas Büchner; Wolfgang E Berdel; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger; Carsten Müller-Tidow; Jan Braess; Karsten Spiekermann; Joachim Kienast; Peter Staib; Andreas Grüneisen; Wolfgang Kern; Albrecht Reichle; Georg Maschmeyer; Carlo Aul; Eva Lengfelder; Maria-Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

7.  Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.

Authors:  Kaaren K Reichard; Qian-Yun Zhang; Lorraine Sanchez; John Hozier; David Viswanatha; Kathryn Foucar
Journal:  Am J Hematol       Date:  2006-03       Impact factor: 10.047

8.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Authors:  Timothy J Ley; Christopher Miller; Li Ding; Benjamin J Raphael; Andrew J Mungall; A Gordon Robertson; Katherine Hoadley; Timothy J Triche; Peter W Laird; Jack D Baty; Lucinda L Fulton; Robert Fulton; Sharon E Heath; Joelle Kalicki-Veizer; Cyriac Kandoth; Jeffery M Klco; Daniel C Koboldt; Krishna-Latha Kanchi; Shashikant Kulkarni; Tamara L Lamprecht; David E Larson; Ling Lin; Charles Lu; Michael D McLellan; Joshua F McMichael; Jacqueline Payton; Heather Schmidt; David H Spencer; Michael H Tomasson; John W Wallis; Lukas D Wartman; Mark A Watson; John Welch; Michael C Wendl; Adrian Ally; Miruna Balasundaram; Inanc Birol; Yaron Butterfield; Readman Chiu; Andy Chu; Eric Chuah; Hye-Jung Chun; Richard Corbett; Noreen Dhalla; Ranabir Guin; An He; Carrie Hirst; Martin Hirst; Robert A Holt; Steven Jones; Aly Karsan; Darlene Lee; Haiyan I Li; Marco A Marra; Michael Mayo; Richard A Moore; Karen Mungall; Jeremy Parker; Erin Pleasance; Patrick Plettner; Jacquie Schein; Dominik Stoll; Lucas Swanson; Angela Tam; Nina Thiessen; Richard Varhol; Natasja Wye; Yongjun Zhao; Stacey Gabriel; Gad Getz; Carrie Sougnez; Lihua Zou; Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Frederick Applebaum; Stephen B Baylin; Rehan Akbani; Bradley M Broom; Ken Chen; Thomas C Motter; Khanh Nguyen; John N Weinstein; Nianziang Zhang; Martin L Ferguson; Christopher Adams; Aaron Black; Jay Bowen; Julie Gastier-Foster; Thomas Grossman; Tara Lichtenberg; Lisa Wise; Tanja Davidsen; John A Demchok; Kenna R Mills Shaw; Margi Sheth; Heidi J Sofia; Liming Yang; James R Downing; Greg Eley
Journal:  N Engl J Med       Date:  2013-05-01       Impact factor: 91.245

9.  Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.

Authors:  K-H Lee; J-H Lee; S-J Choi; J-H Lee; S Kim; M Seol; Y-S Lee; W-K Kim; E-J Seo; C-J Park; H-S Chi; J-S Lee
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483

10.  An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues.

Authors:  Ronjon Chakraverty; Daniel Côté; Jennifer Buchli; Pete Cotter; Richard Hsu; Guiling Zhao; Teviah Sachs; Costas M Pitsillides; Roderick Bronson; Terry Means; Charles Lin; Megan Sykes
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.